Cargando…

Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol

The presence of the Tuberculosis (TB) disease-causing pathogen, Mycobacterium Tuberculosis (Mtb), induces the development of a pathological feature termed granuloma, which the host uses to contain the bacteria. However, the granuloma may dissociate resulting in detrimental caseation of the lung. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Mpotje, Thabo, More, Jessica, Rajkumar-Bhugeloo, Kerishka, Moodley, Denelle, Marakalala, Mohlopheni J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113799/
https://www.ncbi.nlm.nih.gov/pubmed/37090480
http://dx.doi.org/10.12688/wellcomeopenres.19226.1
_version_ 1785027910586859520
author Mpotje, Thabo
More, Jessica
Rajkumar-Bhugeloo, Kerishka
Moodley, Denelle
Marakalala, Mohlopheni J
author_facet Mpotje, Thabo
More, Jessica
Rajkumar-Bhugeloo, Kerishka
Moodley, Denelle
Marakalala, Mohlopheni J
author_sort Mpotje, Thabo
collection PubMed
description The presence of the Tuberculosis (TB) disease-causing pathogen, Mycobacterium Tuberculosis (Mtb), induces the development of a pathological feature termed granuloma, which the host uses to contain the bacteria. However, the granuloma may dissociate resulting in detrimental caseation of the lung. The disease contributes to a growing global burden of lung function challenges, warranting for more understanding of the TB-induced immunopathology. The current study aims to explore in detail host factors that drive pathological features of TB contributing to extensive lung tissue destruction. Lung tissue sections obtained from patients undergoing surgical resection will be processed and analyzed using histopathological assays including Immunohistochemistry, Immunofluorescence, Hematoxylin and Eosin staining and Laser Capture Microdissection. The findings will provide key host factors that associate with exacerbated lung immunopathology during TB.
format Online
Article
Text
id pubmed-10113799
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-101137992023-04-20 Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol Mpotje, Thabo More, Jessica Rajkumar-Bhugeloo, Kerishka Moodley, Denelle Marakalala, Mohlopheni J Wellcome Open Res Study Protocol The presence of the Tuberculosis (TB) disease-causing pathogen, Mycobacterium Tuberculosis (Mtb), induces the development of a pathological feature termed granuloma, which the host uses to contain the bacteria. However, the granuloma may dissociate resulting in detrimental caseation of the lung. The disease contributes to a growing global burden of lung function challenges, warranting for more understanding of the TB-induced immunopathology. The current study aims to explore in detail host factors that drive pathological features of TB contributing to extensive lung tissue destruction. Lung tissue sections obtained from patients undergoing surgical resection will be processed and analyzed using histopathological assays including Immunohistochemistry, Immunofluorescence, Hematoxylin and Eosin staining and Laser Capture Microdissection. The findings will provide key host factors that associate with exacerbated lung immunopathology during TB. F1000 Research Limited 2023-03-28 /pmc/articles/PMC10113799/ /pubmed/37090480 http://dx.doi.org/10.12688/wellcomeopenres.19226.1 Text en Copyright: © 2023 Mpotje T et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Mpotje, Thabo
More, Jessica
Rajkumar-Bhugeloo, Kerishka
Moodley, Denelle
Marakalala, Mohlopheni J
Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol
title Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol
title_full Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol
title_fullStr Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol
title_full_unstemmed Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol
title_short Validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol
title_sort validation of proteins associated with pathological damage in human tuberculosis granulomas: study protocol
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113799/
https://www.ncbi.nlm.nih.gov/pubmed/37090480
http://dx.doi.org/10.12688/wellcomeopenres.19226.1
work_keys_str_mv AT mpotjethabo validationofproteinsassociatedwithpathologicaldamageinhumantuberculosisgranulomasstudyprotocol
AT morejessica validationofproteinsassociatedwithpathologicaldamageinhumantuberculosisgranulomasstudyprotocol
AT rajkumarbhugelookerishka validationofproteinsassociatedwithpathologicaldamageinhumantuberculosisgranulomasstudyprotocol
AT moodleydenelle validationofproteinsassociatedwithpathologicaldamageinhumantuberculosisgranulomasstudyprotocol
AT marakalalamohlophenij validationofproteinsassociatedwithpathologicaldamageinhumantuberculosisgranulomasstudyprotocol